Nesiritide Legal Status: Approval, Research Use, and Regulatory Notes
FDA-approved (2001) for treatment of acutely decompensated heart failure. Available by prescription for hospital/clinic use only. Marketed as Natrecor by Janssen.
Direct Answer
Nesiritide (Natrecor) is FDA-approved for acute decompensated heart failure with initial enthusiasm tempered by subsequent analysis showing limited mortality benefit and possible renal harm at higher doses. Current guidelines reserve it for symptom relief when other therapies are inadequate. It is a validated BNP analog with a well-characterized pharmacology, but its role in HF management has narrowed with evolving evidence.
- Evidence grade
- Level A
- Research status
- FDA Approved
- Category
- Healing & Recovery
- Evidence context
- Acute decompensated heart failure symptom management, BNP/natriuretic peptide pharmacology research
Legal and Regulatory Status
FDA-approved (2001) for treatment of acutely decompensated heart failure. Available by prescription for hospital/clinic use only. Marketed as Natrecor by Janssen.
Approval Stage
Nesiritide is listed as FDA Approved. Approved uses, if any, are indication-specific and do not automatically apply to other claims.
Compliance Notes
- Hypotension is the most significant adverse effect - avoid in patients with SBP <100 mmHg
- Should not be used as primary therapy for cardiogenic shock
- Monitor renal function during infusion
- Limited long-term outcome data - use for symptom relief, not mortality reduction
Evidence Page
For the complete evidence review, see the main Nesiritide guide linked below.
Evidence Snapshot
| Evidence grade | Level A |
|---|---|
| Research status | FDA Approved |
| Best supported outcomes | Dyspnea Relief in Acute HF (Level A), Hemodynamic Improvement (Level A), and Renal Function Concerns (Level B) |
| Primary citation count | 3 |
| Last reviewed | 2026-08-27 |
Quick Answers
What is the legal status of Nesiritide?
FDA-approved (2001) for treatment of acutely decompensated heart failure. Available by prescription for hospital/clinic use only. Marketed as Natrecor by Janssen.
What is the evidence level for Nesiritide?
Nesiritide is rated Level A. Its current research status is FDA Approved.
What is Nesiritide best known for?
Acute decompensated heart failure symptom management, BNP/natriuretic peptide pharmacology research.
Where can I read the full Nesiritide evidence review?
The full evidence review is available at https://examinepeptides.com/library/nesiritide.
Related Guides
How to Cite This Page
ExaminePeptides. "Nesiritide Legal Status: Approval, Research Use, and Regulatory Notes." Last reviewed 2026-08-27. https://examinepeptides.com/answers/nesiritide-legal-status/
This static answer page is built for fast indexing and direct citation. It summarizes the matching full evidence review and links back to primary sources where the source database includes them.